FacebookTwitterRedditEmail

How Patients Who “Kill the Messenger” Are Pharma’s Best Salespeople

Photo by Charles Williams | CC BY 2.0

“Prince was not addicted to pain medication. Prince had a medical condition — chronic pain –which is criminally under-treated…. Physical dependence is not addiction.” So reads one of many articles that defend opioids and blame their restrictions for the nation’s opioid crisis. Right.

When journalists present evidence of a prescription drug being dangerous, ineffective, unethically marketed and even unnecessary we are often met with: “How dare you suggest I am not sick?” “You’re not taking my drugs!” They sound like gun advocates whose response to better background check laws for guns is “you’re not taking my gun.”

Thanks to aggressive Pharma marketing, seven out of ten Americans now take a prescription drug and many of the drugs are far from safe.

* 100 people a day die in the US from opioids.

* Statins are linked to memory loss

* GERD meds are linked to early death risks

* SSRI antidepressants are linked to suicide

Pharma has succeeded, through millions of dollars of advertising, in doing two cagey things: it has convinced people who might actually be fine that they have “depression,” GERD and other conditions and it has downplayed the risks of drugs to treat those conditions. Pharma’s maneuver affects more than the drug takers–it raises everyone’s health care costs and taxes through selling expensive, brand-name drugs. Usually safer and less expensive drugs are available–if people even need drugs at all. Often they don’t.

Consider SSRI antidepressants. Before the advent of Prozac, depression was not a permanent condition for which people took life-long drugs. It was a self-limited condition that would go away on its own, respond to psychotherapy and/or respond to short-term drugs. Now, roughly a quarter of the population takes antidepressants, sometimes, shockingly, for decades. Often their “depression” is really problems with money, health, jobs and family. When SSRI antidepressants stop working because they have been used for too long or don’t work to begin with because the person never had “depression,” Pharma tells patients they need to add more expensive drugs, furthering profiting, and patients comply. No wonder Pharma is the third most lucrative industry in the US.

Whereas it takes thirty seconds for a doctor to prescribe such psychoactive drugs, it can take years for a person to titrate off them, faced with a host of very unpleasant withdrawal symptoms. SSRI antidepressants also cause weight gain, sexual dysfunction and sometimes bizarre and violent behavior.

Psychoactive drugs are especially dangerous in children. Today, millions of children are given drugs for ADHD, oppositional defiant disorder, obsessive-compulsive disorders, mixed manias, pervasive development disorders and more, pushed by their parents, doctors and teachers. Their chances of going on to lead drug-free lives are very slim—-they have never been “straight”—- and Pharma has actual marketing plans to keep children on such drugs as life-long customers when they leave home.

GERD medicines (proton pump inhibitors or PPIs) which millions have been convinced to use are linked to dangerous “C dif” infections, osteoporosis, bone fractures and an increased risk of death. Like statins, which were among the most popular drugs in the world, GERD meds are not as safe as originally presented. Worse–most users do not have GERD but simple heartburn.

And opioids? In addition to addiction and death, they are linked to hormonal changes, constipation, a decrease in immune responses, fracture risks, liver and kidney risks, cardiopulmonary, pulmonary and congestive heart problems, sleep apnea and mental problems. In some cases, opioids actually cause rather than relieve pain a phenomenon called opioid-induced hyperalgesia (OIH).

To sell its high priced, often dangerous drugs Pharma has long created phony “patient groups” who lobby Congress and state Medicaid programs to pry loose our tax dollars. But “kill the messenger” patients are just as useful to Pharma’s marketing plans.

After a recent scientific study found “Adult ADHD” to be exaggerated if it exists at all this is what one patient wrote:

“Executive dysfunction [adult ADHD[ is real and f***you for suggesting otherwise…You should feel really bad for publishing this f*** abomination. Way to invalidate millions of people and their lived experiences.”

Rather than anger at doctors who hooked them on opioids or ADHD stimulant drugs like Adderall, Concerta and Vyvanse, these patients want to kill the messenger––journalists who report the scam. And Pharma likes that just fine.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
April 01, 2020
Steve Early - Suzanne Gordon
No Pandemic-Related Pause? VA Privatization Leaves Veterans Waist Deep in Another Big Muddy 
Kenneth Surin
The UK and Covid-19 Crisis
Jack Wareham - Dylan Burgoon
“Whose University? Our University!” The Struggle for a COLA at UC Berkeley
Erik Molvar
Oil industry Exploits Pandemic as Excuse to Dodge Federal Regulations, Fees
Robert Jensen
Apocalypse, Now and Forever
Jake Johnston – Kira Paulemon
COVID-19 in Haiti: the Current Response and Challenges
Jen Moore
Guatemalan Water Protectors Persist, Despite Mining Company Threats
Danny Shaw
“The Coronavirus is Man-Made:” the Conspiracy Theory Trap 
Nafeez Ahmed
Former WHO Director: 8-Week Suppression Strategy Could Stop US COVID Crisis in Its Tracks
Frances Madeson
Death Camps in the Making: New York’s Prisons During a Time of Pandemic
Clark T. Scott
The White House and the CDC are United in Stupidity
George Ochenski
What Does COVID-19 Have to Do With Industrial Pollution?
Norman Solomon
Trump’s Mass Negligent Homicide Doesn’t Let Democratic Leaders Off the Hook
Scott Owen
Another New Peace
Elizabeth Schmidt
Lessons From Africa: Military Intervention Fails to Counter Terrorism
Greta Anderson
What’s the Hang Up on Releasing Adult Lobos?
Ted Rall
The Speech Trump Must But Cannot Give
Marshall Sahlins
Trumpty’s Country
March 31, 2020
Jonathan Cook
Netanyahu Uses Coronavirus to Lure Rival Gantz into ‘Emergency’ Government
Vijay Prashad, Du Xiaojun – Weiyan Zhu
Growing Xenophobia Against China in the Midst of CoronaShock
Patrick Cockburn
Trump’s Chernobyl Moment: the US May Lose Its Status as World Superpower and Not Recover
Roger Harris
Beyond Chutzpah: US Charges Venezuela With Nacro-Terrorism
M. K. Bhadrakumar
Has America Reached Its Endgame in Afghanistan?
Thomas Klikauer
COVID-19 in Germany: Explaining a Low Death Rate
Dave Lindorff
We’ve Met the Enemy and It’s a Tiny Virus
Binoy Kampmark
Barbaric Decisions: Coronavirus, Refusing Bail and Julian Assange
Nicolas J S Davies
Why is the U.S. so Exceptionally Vulnerable to Covid-19?
James Bovard
The Deep State’s Demolition of Democracy
Michael Doliner
Face Off: the Problem With Social Distancing
John Feffer
The Politics of COVID-19
Mel Gurtov
Trump’s Cure and Our Disease
Howard Lisnoff
The Fault Lines of a Failed Society Begin to Open Up Into Chasms
Nino Pagliccia
Cuba: An Example of Solidarity In a Time of Crisis
Ralph Nader
Out of the Coronavirus Crisis Can Come Efficient Historic Changes for Justice
Thomas Stephens
Apocalyptic and Revolutionary Education in Times of Pandemic
Edward Martin
Erik Olin Wright and the Anti-Capitalist Economy
March 30, 2020
Marshall Auerback
Washington Uses the Pandemic to Create a $2 Trillion Slush Fund for Its Cronies
Ron Jacobs
Going After Maduro
Justin Podur
When Economists Try to Solve Health Crises, the Results Can Often be Disastrous
Thomas Knapp
Decarceration: COVID-19 is Opportunity Knocking
Arshad Khan - Meena Miriam Yust
Dying Planet and a Virus Unleashed
William Astore
How My Dad Predicted the Decline of America
Seth Sandronsky
Reclaiming Vacant Homes in the COVID-19 Pandemic
John G. Russell
Racial Profiling Disorder: the All-American Pandemic
Vijay Prashad, Paola Estrada, Ana Maldonado, and Zoe PC
As the World Tackles the COVID-19 Pandemic, the U.S. Raises the Pressure on Venezuela
FacebookTwitterRedditEmail